B-vitamin Treatment Modifies the Mortality Risk Associated with Calcium Channel Blockers in Patients with Suspected Stable Angina Pectoris: A Prospective Cohort Study

BACKGROUND: Calcium channel blockers (CCBs) are used for the treatment of cardiovascular disease (CVD), including angina pectoris, and hypertension; however, the effect on survival remains uncertain. CCBs impair fibrinolysis and have been linked to elevated plasma homocysteine (Hcy), a CVD risk mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhar, Indu, Svingen, Gard FT., Bjørnestad, Espen Ø., Ulvik, Arve, Saeed, Sahrai, Nygård, Ottar K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Nutrition 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375456/
https://www.ncbi.nlm.nih.gov/pubmed/37121550
http://dx.doi.org/10.1016/j.ajcnut.2023.04.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375456/
https://www.ncbi.nlm.nih.gov/pubmed/37121550
http://dx.doi.org/10.1016/j.ajcnut.2023.04.033

Ejemplares similares